BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li J, Tong D, Chen F, Song B, Wang Y, Liu Y, Zhang X, Liu N, Xu Y, Li Y, Yin X, Liu W. Inflammatory cytokines enhance procoagulant activity of platelets and endothelial cells through phosphatidylserine exposure in patients with essential hypertension. J Thromb Thrombolysis 2021;51:933-40. [PMID: 33219895 DOI: 10.1007/s11239-020-02342-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Tong D, Song B, Xie F, Zhang G, Hao X, Li W, Chi H, Wang W, Shao Y. Inflammatory cytokines induce neutrophil extracellular traps interaction with activated platelets and endothelial cells exacerbate coagulation in moderate and severe essential hypertension. J Hypertens 2022. [PMID: 35950987 DOI: 10.1097/HJH.0000000000003250] [Reference Citation Analysis]
2 Yan M, Xu M, Li Z, An Y, Wang Z, Li S, Chen Y, Xia Y, Wang L, Wang L, Ji S, Dong W, Shi J, Gao C. TMEM16F mediated phosphatidylserine exposure and microparticle release on erythrocyte contribute to hypercoagulable state in hyperuricemia. Blood Cells Mol Dis 2022;96:102666. [PMID: 35567997 DOI: 10.1016/j.bcmd.2022.102666] [Reference Citation Analysis]
3 Yu Y, Jiang P, Sun P, Su N, Lin F. Pulmonary coagulation and fibrinolysis abnormalities that favor fibrin deposition in the lungs of mouse antibody-mediated transfusion-related acute lung injury. Mol Med Rep 2021;24:601. [PMID: 34165170 DOI: 10.3892/mmr.2021.12239] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Becker RC, Bode C. Medical publishing during the COVID-19 pandemic: then and now. J Thromb Thrombolysis 2021;51:1101-6. [PMID: 33687610 DOI: 10.1007/s11239-021-02422-6] [Reference Citation Analysis]
5 Paar V, Wernly B, Zhou Z, Motloch LJ, Hoppe UC, Egle A, Lichtenauer M. Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory? J Thromb Thrombolysis 2021;51:226-31. [PMID: 32632558 DOI: 10.1007/s11239-020-02212-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
6 Vlachou M, Drebes A, Candilio L, Weeraman D, Mir N, Murch N, Davies N, Coghlan JG. Pulmonary thrombosis in Covid-19: before, during and after hospital admission. J Thromb Thrombolysis 2021;51:978-84. [PMID: 33386559 DOI: 10.1007/s11239-020-02370-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
7 Mercurio I, Tragni V, Busto F, De Grassi A, Pierri CL. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies. Cell Mol Life Sci 2021;78:1501-22. [PMID: 32623480 DOI: 10.1007/s00018-020-03580-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 14.5] [Reference Citation Analysis]